Cigna Competitors
| CI Stock | USD 290.22 0.49 0.17% |
Cigna Corp vs Cardinal Health Correlation
Poor diversification
The correlation between Cigna Corp and CAH is 0.66 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cigna Corp and CAH in the same portfolio, assuming nothing else is changed.
Moving against Cigna Stock
The Cigna Corp's current Return On Equity is estimated to increase to 0.10, while Return On Tangible Assets are projected to decrease to 0.02. As of now, Cigna Corp's Intangible Assets are increasing as compared to previous years. The Cigna Corp's current Intangibles To Total Assets is estimated to increase to 0.46, while Total Assets are projected to decrease to under 91.2 B.Cigna Corp Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Cigna Corp and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Cigna and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Cigna Corp does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Cigna Stock performing well and Cigna Corp Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cigna Corp's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ELV | 1.60 | 0.10 | 0.04 | 0.11 | 2.80 | 3.40 | 19.95 | |||
| COR | 1.19 | (0.02) | (0.02) | (0.05) | 2.29 | 2.01 | 10.81 | |||
| REGN | 1.56 | 0.24 | 0.13 | 0.71 | 1.47 | 3.40 | 8.86 | |||
| ZTS | 1.08 | 0.04 | 0.03 | 0.10 | 1.13 | 2.74 | 8.16 | |||
| HUM | 2.05 | (0.42) | 0.00 | (0.23) | 0.00 | 3.79 | 27.31 | |||
| IDXX | 1.26 | (0.23) | 0.00 | (0.18) | 0.00 | 3.61 | 10.16 | |||
| CVS | 1.42 | (0.04) | (0.01) | 0.00 | 3.14 | 2.57 | 16.76 | |||
| CNC | 1.89 | 0.21 | 0.08 | 0.22 | 2.50 | 4.58 | 17.20 | |||
| BDX | 1.15 | 0.24 | 0.23 | 0.31 | 0.72 | 3.22 | 7.13 | |||
| CAH | 1.14 | 0.17 | 0.07 | (0.68) | 1.42 | 2.54 | 13.93 |
Cross Equities Net Income Analysis
Compare Cigna Corp and related stocks such as Elevance Health, Cencora, and Regeneron Pharmaceuticals Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ELV | 172.4 M | 2.6 B | 2.7 B | 2.7 B | 2.6 B | 2.6 B | 2.5 B | 3.8 B | 3.8 B | 4.8 B | 4.6 B | 6.1 B | 5.9 B | 6 B | 6 B | 5.7 B | 3.3 B |
| COR | (207.7 M) | 719 M | 433.7 M | 276.5 M | (134.9 M) | 1.4 B | 414.5 M | 1.7 B | 855.4 M | (3.4 B) | 1.5 B | 1.7 B | 1.7 B | 1.5 B | 1.6 B | 1.8 B | 1.9 B |
| REGN | (3.3 M) | (221.8 M) | 750.3 M | 424.4 M | 348.1 M | 636.1 M | 895.5 M | 1.2 B | 2.4 B | 2.1 B | 3.5 B | 8.1 B | 4.3 B | 4 B | 4.4 B | 4.5 B | 4.7 B |
| ZTS | (100 M) | 245 M | 436 M | 504 M | 583 M | 339 M | 821 M | 864 M | 1.4 B | 1.5 B | 1.6 B | 2 B | 2.1 B | 2.3 B | 2.5 B | 2.7 B | 2.8 B |
| IDXX | 3.2 M | 161.8 M | 178.3 M | 187.8 M | 181.9 M | 192.1 M | 222 M | 263.1 M | 377 M | 427.7 M | 581.8 M | 744.8 M | 679.1 M | 845 M | 887.9 M | 1.1 B | 1.1 B |
| CVS | 210.2 M | 3.5 B | 3.9 B | 4.6 B | 4.6 B | 5.2 B | 5.3 B | 6.6 B | (594 M) | 6.6 B | 7.2 B | 8 B | 4.3 B | 8.3 B | 4.6 B | 1.8 B | 2.6 B |
| CNC | (9.4 M) | 111.2 M | 2 M | 165.1 M | 271 M | 355 M | 562 M | 828 M | 900 M | 1.3 B | 1.8 B | 1.3 B | 1.2 B | 2.7 B | 3.3 B | (6.7 B) | (6.3 B) |
| BDX | 88 M | 1.2 B | 1.3 B | 1.2 B | 695 M | 976 M | 1.1 B | 311 M | 1.2 B | 874 M | 2.1 B | 1.8 B | 1.5 B | 1.7 B | 1.7 B | 1.9 B | 2 B |
| CAH | 6 M | 1.1 B | 334 M | 1.2 B | 1.2 B | 1.4 B | 1.3 B | 256 M | 1.4 B | (3.7 B) | 611 M | (938 M) | 330 M | 852 M | 1.6 B | 1.8 B | 1.9 B |
Cigna Corp and related stocks such as Elevance Health, Cencora, and Regeneron Pharmaceuticals Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Cigna Corp financial statement analysis. It represents the amount of money remaining after all of Cigna Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Cigna Corp Competitive Analysis
The better you understand Cigna Corp competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Cigna Corp's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Cigna Corp's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Cigna Corp Competition Performance Charts
Five steps to successful analysis of Cigna Corp Competition
Cigna Corp's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Cigna Corp in relation to its competition. Cigna Corp's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Cigna Corp in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Cigna Corp's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Cigna Corp, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Cigna Corp position
In addition to having Cigna Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run World Allocation Funds Thematic Idea Now
World Allocation Funds
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Cigna Corp Correlation with its peers. For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is there potential for Health Care Providers & Services market expansion? Will Cigna introduce new products? Factors like these will boost the valuation of Cigna Corp. Projected growth potential of Cigna fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Cigna Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Dividend Share 6.04 | Earnings Share 22.18 | Revenue Per Share | Quarterly Revenue Growth 0.104 |
Cigna Corp's market price often diverges from its book value, the accounting figure shown on Cigna's balance sheet. Smart investors calculate Cigna Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Cigna Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cigna Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cigna Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cigna Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.